文献速递瘢痕与激光创面修复

重组人III型胶原蛋白通过调节I/III型胶原比例改善增生性瘢痕

Recombinant Human Collagen Type III Improves Hypertrophic Scarring by Regulating the Ratio of Type I/III Collagen.
PubMed 文献 · J Burn Care Res · 2024-01-01

本研究开发了重组人III型胶原蛋白,经液相色谱-串联质谱确认其氨基酸序列与天然人III型胶原高度同源,且无细胞毒性、不引起皮肤刺激和致敏。体外实验显示该蛋白可被成纤维细胞摄取,促进天然III型胶原合成并降低I/III型胶原比例,同时促进成纤维细胞增殖。兔耳瘢痕局部注射60天后瘢痕显著减轻,温哥华瘢痕量表各指标评分均显著降低。

要点

  • 重组人III型胶原蛋白与天然人III型胶原高度同源,无细胞毒性、无皮肤刺激和致敏。
  • 该蛋白可被成纤维细胞摄取,促进III型胶原合成多于I型,降低I/III型胶原比例。
  • 兔耳瘢痕局部注射60天后瘢痕显著减轻,温哥华瘢痕量表各指标评分均显著降低。

核心结论

  • 重组人III型胶原蛋白可被成纤维细胞摄取并促进天然胶原合成尤其是III型胶原,从而降低I/III型胶原比例并改善增生性瘢痕。

研究设计与样本

  • 本研究为实验研究,包含重组人III型胶原蛋白的制备与表征、体外成纤维细胞实验及兔耳瘢痕模型体内实验。

主要发现

  • 液相色谱-串联质谱确定重组人III型胶原蛋白氨基酸序列,确认其与天然人III型胶原高度同源。
  • 重组人III型胶原蛋白无细胞毒性,未引起皮肤刺激和致敏。
  • 免疫荧光和蛋白质印迹分析组氨酸显示重组人III型胶原蛋白被成纤维细胞摄取。
  • 重组人III型胶原蛋白促进成纤维细胞合成天然III型胶原,III型胶原含量增加较I型更明显,降低I/III型胶原比例。
  • 5-乙炔基-2'-脱氧尿苷染色实验提示成纤维细胞增殖增强。

关键数值与推荐

  • 兔耳瘢痕局部注射重组人III型胶原蛋白60天后瘢痕显著减轻,温哥华瘢痕量表评估显示所有指标评分均显著降低。
  • 蛋白质印迹和天狼星红染色显示瘢痕组织中天然III型胶原增加多于I型胶原,I/III型比例降低。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Hypertrophic scar development is a complication associated with wound healing, impacting local appearance and function. The type I/III collagen ratio affects the extent of hypertrophic scarring; a reduced ratio can ameliorate this. In this study, recombinant human collagen type III was developed. Liquid chromatography-tandem mass spectrometry was used to determine its amino acid sequence and confirm its high level of homology with natural human type III collagen. Recombinant human collagen type III displayed no cytotoxicity and did not confer skin irritation and sensitization. Immunofluorescence and western blot analyses of histidine following incubation with fibroblasts suggested cell entry of recombinant human collagen type III. Furthermore, recombinant human collagen type III promoted the synthesis of the natural type III collagen in fibroblasts, resulting in a more obvious increase of type III collagen content in fibroblasts than that of type I collagen, and then decreased the ratio of type I/III collagen. The results of 5-ethynyl-2'-deoxyuridine staining assay suggested enhanced fibroblast proliferation. Following local injection of recombinant human collagen type III, rabbit ear scarring was significantly reduced after 60 days. Vancouver Scar Scale evaluation showed that all index scores were significantly reduced. Western blotting and Picro-Sirius red staining showed that the natural type III collagen increase in scar tissue was greater than that of type I collagen, decreasing the type I/III ratio. In summary, recombinant human collagen type III can be taken up by fibroblasts and promote natural collagen synthesis-especially that of type III-thereby reducing the type I/III ratio and improving hypertrophic scarring.

来源:J Burn Care Res,查看原文。版权归原作者所有。

引用

  1. Lin-Hui L, Yuan-Yuan Z, Ming-Yu L, et al. Recombinant Human Collagen Type III Improves Hypertrophic Scarring by Regulating the Ratio of Type I/III Collagen. J Burn Care Res. 2024. PMID: 38477626. doi:10.1093/jbcr/irae040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。